1-5 of 5
Robert Hawkins
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2400: Mechanisms of resistance to immuno and targeted therapies in acral melanoma

Rebecca J. Lee, Maria Romina Girotti, Amaya Viros, Franziska Baenke, Amit Mandal, Garima Khandelwal, John Bridgeman, Elena Galvani, Gabriela Gremel, Milena Kalaitsidou, Garry Ashton, Isabel Peset, Matthew Smith, Jacqueline Swan, Kang Zeng, Haoran Tang, Caron Abbey, Robert Hawkins, Alberto Fusi, Crispin Miller, David Gilham, Nathalie Dhomen, Paul Lorigan, Richard Marais
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2400.
https://doi.org/10.1158/1538-7445.AM2016-2400
Published: 15 July 2016
View article titled, Abstract 2400: Mechanisms of resistance to immuno and targeted therapies in acral melanoma
Journal Articles

A phase II study of CP-675,206 in advanced gastric and esophageal adenocarcinoma: Clinical and immunological results.

Christy Ralph, Eyad Elkord, Fiona Thistlethwaite, Debbie Burt, Carmel Langan, Catriona Parker, Peter Stern, Robert Hawkins
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 2835.
Published: 01 May 2008
View article titled, A phase II study of CP-675,206 in advanced gastric and esophageal adenocarcinoma: Clinical and immunological results.
Journal Articles

Safety, tolerability, pharmacokinetic and escalating single doses of PCK3145 in patients with metastatic hormone resistant prostatic cancer (HRPC)

Helene Dulude, Chandra Panchal, Luc Daigneault, Seema Garde, Shafaat A. Rabbani, Richard Cowan, Anne Armstrong, Marcia Ruiz, Robert Hawkins
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1032.
Published: 01 April 2004
View article titled, Safety, tolerability, pharmacokinetic and escalating single doses of PCK3145 in patients with metastatic hormone resistant prostatic cancer (HRPC)
Journal Articles

Modified vaccinia Ankara (MVA) expressing the tumour associated antigen 5T4 (TroVax) induces immune responses in late stage colorectal cancer patients in a phase I/II clinical trial

Miles W. Carroll, Richard Harrop, Noel Connolly, Irina Redchenko, Matthew Ryan, Noel Drury, Michelle Kelleher, Sue Kingsman, Robert Hawkins
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 326.
Published: 01 April 2004
View article titled, Modified vaccinia Ankara (MVA) expressing the tumour associated antigen 5T4 (TroVax) induces immune responses in late stage colorectal cancer patients in a phase I/II clinical trial
Journal Articles

Carcinoembryonic Antigen (CEA)-specific T-Cell Activation in Colon Carcinoma Induced by Anti-CD3×Anti-CEA Bispecific Diabodies and B7×Anti-CEA Bispecific Fusion Proteins

Philipp Holliger, Oliver Manzke, Mary Span, Robert Hawkins, Bernd Fleischmann, Liu Qinghua, Jürgen Wolf, Volker Diehl, Olivier Cochet, Greg Winter, Heribert Bohlen
Journal: Cancer Research
Cancer Res (1999) 59 (12): 2909–2916.
Published: 15 June 1999
View article titled, Carcinoembryonic Antigen (CEA)-specific T-Cell Activation in Colon Carcinoma Induced by Anti-CD3×Anti-CEA Bispecific Diabodies and B7×Anti-CEA Bispecific Fusion Proteins
Open the PDF for Carcinoembryonic Antigen (CEA)-specific T-Cell Activation in Colon Carcinoma Induced by Anti-CD3×Anti-CEA Bispecific Diabodies and B7×Anti-CEA Bispecific Fusion Proteins in another window